Ebola Response: The Red Cross says Congo’s Ebola outbreak has not peaked and could last a year, warning that trust-building and hygiene measures are being undermined by attacks and weak sanitation. Public Health & Safety: Taiwan’s CDC linked a Kaohsiung hospital dengue cluster to an imported Vietnam case, expanding testing to more than 1,400 people while stressing mosquito control. Medicine Supply Watch: Malaysia’s health ministry reports most medicines have over 90 days of stock, but flags high-risk items like key cancer and antibiotic products under close monitoring. Drug Regulation: India restricts cough syrup sales to licensed pharmacies in villages after contamination-linked child deaths, tightening rules ahead of broader scrutiny. Healthcare Workforce: A new report warns “workforce stability” may hide retention risk, citing delayed disengagement, schedule strain, and burnout. Innovation & Funding: Icarus Medical raises $7.2m Series A for orthopedic bracing commercialization, while Dimerix licenses DMX-200 rights across Greater China and parts of Asia to Everest Medicines. Hospital Tech & Care: Ireland’s Mater Hospital begins Aquablation prostate treatments, and the HSE faces a €300k fine over a 2018 Tullamore patient data breach. Clinical Research: The Cystic Fibrosis Foundation backs Israeli biotech SpliSense with $13m to develop an inhaled therapy showing lung-function improvements in early trials.